A five year experience of the use of factor IX type DE(I) concentrate for the treatment of Christmas disease of Oxford

British Journal of Haematology
J L LaneT J Snape

Abstract

A survey is presented of the use of the Oxford type DE(I) II-IX-X concentrate in the treatment of Christmas disease in Oxford from January 1970 to September 1974. 72 different patients were treated with a total of 2436 bottles of this concentrate from 143 different batches (each bottle containing 800-1000 units of factor IX). Although most doses were given for the treatment of minor haemorrhages into joints and muscles, 717 bottles of concentrate were used to treat 11 patients who underwent 14 major surgical operations. No episode of intravascular clotting or pulmonary embolism was seen in any patient receiving the concentrate. A detailed study of the plasma levels of factor V, VIII, total progressive antithrombin, platelets and fibrinogen degradation products was carried out before and after transfusion of type DE(I) concentrate in 14 patients. No significant alteration in those factors was found after the transfusion.

References

Feb 24, 1973·Lancet·N StathakisC D Gardikas
Dec 8, 1973·Lancet·M AbergU Hedner
Feb 14, 1974·The New England Journal of Medicine
Sep 1, 1970·British Journal of Haematology·R BiggsM Hadden
Dec 1, 1950·Journal of Applied Physiology·G BRECHER, E P CRONKITE

❮ Previous
Next ❯

Citations

Nov 1, 1981·Vox Sanguinis·S Chandra, H G Brummelhuis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.